Works matching DE "GLUCAGON-like peptide 1"

Results: 3106

SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4603, doi. 10.1111/dom.16494

By:

Luedde, Mark;
Sedighi, Jamschid;
Hippe, Hans‐Joerg;
Sossalla, Samuel;
Kostev, Karel

Publication type:

Article

Progression of cardiac dysfunction in patients with type 2 diabetes without overt cardiovascular disease: A three‐year follow‐up echocardiographic study (DIACAR).

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4581, doi. 10.1111/dom.16457

By:

Antakly Hanon, Yara;
Moeuf, Yoann;
Garçon, Philippe;
Kalaydjian, Aline;
Banu, Isabela;
Voican, Adela;
Dupuy, Olivier;
Cador, Romain;
Komajda, Michel

Publication type:

Article

A case series of incidents reported to webAIRS relating to glucagon-like peptide 1 agonist use.

Published in:

Anaesthesia & Intensive Care, 2025, v. 53, n. 4, p. 220, doi. 10.1177/0310057X241311597

By:

Lam, Clayton YX;
Lin, D-Yin;
Endlich, Yasmin

Publication type:

Article

In this issue.

Published in:: Virchows Archiv: European Journal of Pathology, 2025, v. 486, n. 6, p. 1113, doi. 10.1007/s00428-025-04146-x
Publication type:: Article

GLP- 1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades.

Published in:

Virchows Archiv: European Journal of Pathology, 2025, v. 486, n. 6, p. 1317, doi. 10.1007/s00428-025-04098-2

By:

Watanabe, Hirofumi;
Fujishima, Fumiyoshi;
Yamazaki, Yuto;
Imamura, Masayuki;
Hijioka, Susumu;
Hara, Kazuo;
Kuwahara, Takamichi;
Yatabe, Yasushi;
Sakamoto, Kazuhiro;
Shiga, Hisashi;
Kawaguchi, Tomohiro;
Suzuki, Hiroyoshi;
Kanbayashi, Yumi;
Ohkoshi, Akira;
Shimada, Muneaki;
Niikawa, Hiromichi;
Sato, Mami;
Fujio, Atsushi;
Masui, Toshihiko;
Kasai, Yosuke

Publication type:

Article

Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma.

Published in:

Molecular Brain, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13041-025-01224-8

By:

Mouhammad, Zaynab A.;
Rombaut, Anne;
Bermúdez, Mariana Yolotzin García;
Vohra, Rupali;
Tribble, James R.;
Williams, Pete A.;
Kolko, Miriam

Publication type:

Article

GLP‐1s, SGLT2s associated with lower risk of Alzheimer's disease.

Published in:: Brown University Psychopharmacology Update, 2025, v. 36, n. 8, p. 7, doi. 10.1002/pu.31339
Publication type:: Article

Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies.

Published in:

Life (2075-1729), 2025, v. 15, n. 6, p. 843, doi. 10.3390/life15060843

By:

Trapanese, Vincenzo;
Dagostino, Annamaria;
Natale, Maria Resilde;
Giofrè, Federica;
Vatalaro, Clara;
Melina, Melania;
Cosentino, Francesca;
Sergi, Silvia;
Imoletti, Felice;
Spagnuolo, Rocco;
Arturi, Franco

Publication type:

Article

Obesity, metrics of central adiposity, and prognostic significance in heart failure with preserved and mildly reduced ejection fraction.

Published in:

European Heart Journal, 2025, v. 46, n. 25, p. 2391, doi. 10.1093/eurheartj/ehaf198

By:

Marques, Pedro;
Ferreira, João Pedro

Publication type:

Article

Sodium-Glucose Cotransporter 2 Inhibitors, Erythrocytosis, and Thrombosis in Adults With Type 2 Diabetes.

Published in:

JAMA Network Open, 2025, v. 8, n. 6, p. e2517086, doi. 10.1001/jamanetworkopen.2025.17086

By:

Lewis, Maor;
Burrack, Nitzan;
Heymann, Anthony;
Grossman, Alon;
Neuman, Tsipora;
Abuhasira, Ran

Publication type:

Article

Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 6, p. 807, doi. 10.3390/ph18060807

By:

Vafeidou, Kyriaki;
Psoma, Ourania;
Dimakopoulos, Georgios;
Apostolidis, Evangelos;
Sarvani, Anastasia;
Gavriilaki, Eleni;
Doumas, Michael;
Tsimihodimos, Vassilios;
Kotsa, Kalliopi;
Koufakis, Theocharis

Publication type:

Article

Another year over -- and here's what we've done!

Published in:

Journal of Diabetes Nursing, 2024, v. 28, n. 6, p. 1

By:

Down, Su

Publication type:

Article

Conference news: Highlights from the 84th Scientific Sessions of the American Diabetes Association.

Published in:: Journal of Diabetes Nursing, 2024, v. 28, n. 4, p. 1
Publication type:: Article

Incretins: How we got here, where we're at and what is coming next.

Published in:

Journal of Diabetes Nursing, 2024, v. 28, n. 1, p. 1

By:

Morris, David

Publication type:

Article

Latest news: FLASH-UK study, tirzepatide marketing authorisation, Dexcom G7 launch and GLP-1 RA shortages: Stay abreast of the latest news that could impact diabetes nursing.

Published in:: Journal of Diabetes Nursing, 2022, v. 26, n. 5, p. 1
Publication type:: Article

GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021.

Published in:

Journal of Diabetes Nursing, 2021, v. 25, n. 1, p. 1

By:

Morris, David

Publication type:

Article

PIONEER trials: Oral semaglutide.

Published in:: Journal of Diabetes Nursing, 2019, v. 23, n. 3, p. 2
Publication type:: Article

Service evaluation: A diabetes service in the non-alcoholic fatty liver disease and post-liver-transplant clinics.

Published in:

Journal of Diabetes Nursing, 2018, v. 22, n. 5, p. 1

By:

Phillips, Angela

Publication type:

Article

A practical guide to management of youth-onset type 2 diabetes.

Published in:

Journal of Diabetes Nursing, 2018, v. 22, n. 5, p. 1

By:

Candler, Toby;
Rinn, Sophie;
Hamilton-Shield, Julian

Publication type:

Article

The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes.

Published in:

Journal of Diabetes Nursing, 2018, v. 22, n. 5, p. 1

By:

Down, Su

Publication type:

Article

Therapies in non-alcoholic steatohepatitis ( NASH).

Published in:

Liver International, 2017, v. 37, p. 97, doi. 10.1111/liv.13302

By:

Oseini, Abdul M.;
Sanyal, Arun J.

Publication type:

Article

GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c- JNK.

Published in:

Liver International, 2013, v. 33, n. 5, p. 794, doi. 10.1111/liv.12120

By:

Zhang, Lili;
Yang, Mengliu;
Ren, Hong;
Hu, Huaidong;
Boden, Guenther;
Li, Ling;
Yang, Gangyi

Publication type:

Article

Glucagon like-peptide 1 receptor and the liver.

Published in:

Liver International, 2011, v. 31, n. 9, p. 1243, doi. 10.1111/j.1478-3231.2011.02626.x

By:

Pedersen, Jens;
Holst, Jens Juul

Publication type:

Article

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.

Published in:

Liver International, 2011, v. 31, n. 9, p. 1285, doi. 10.1111/j.1478-3231.2011.02462.x

By:

Svegliati-Baroni, Gianluca;
Saccomanno, Stefania;
Rychlicki, Chiara;
Agostinelli, Laura;
De Minicis, Samuele;
Candelaresi, Cinzia;
Faraci, Graziella;
Pacetti, Deborah;
Vivarelli, Marco;
Nicolini, Daniele;
Garelli, Paolo;
Casini, Alessandro;
Manco, Melania;
Mingrone, Geltrude;
Risaliti, Andrea;
Frega, Giuseppe N.;
Benedetti, Antonio;
Gastaldelli, Amalia

Publication type:

Article

Weight‐loss drugs appear beneficial for patients with substance use disorders.

Published in:: Brown University Psychopharmacology Update, 2025, v. 36, n. 2, p. 1, doi. 10.1002/pu.31260
Publication type:: Article

A look at the GLP‐1 agonists.

Published in:

Brown University Psychopharmacology Update, 2023, v. 34, n. 9, p. 7, doi. 10.1002/pu.31062

By:

Price, Lawrence H.

Publication type:

Article

Oral glucagon-like peptide 1 analogue ameliorates glucose intolerance in db/db mice.

Published in:

Biotechnology Letters, 2022, v. 44, n. 10, p. 1149, doi. 10.1007/s10529-022-03288-1

By:

Zhang, Hanlin;
Dong, Meng;
Yuan, Shouli;
Jin, Wanzhu

Publication type:

Article

hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair.

Published in:

Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00526-0

By:

Wang, Wei;
Wang, Yahao;
Chi, Jingwei;
Tan, Xiaojun;
Hu, Jianxia;
Ma, Xiaolong;
Sun, Xiaofang;
Che, Kui;
Lv, Wenshan;
Wang, Yangang

Publication type:

Article

Lixisenatide ameliorated lipopolysaccharide (LPS)‐induced expression of mucin and inflammation in bronchial epithelial cells.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 1, p. 1, doi. 10.1002/jbt.23618

By:

Xu, Leiming;
Chen, Guoping;
Zhang, Leiming;
He, Aifeng;
Li, Yong

Publication type:

Article

Loxenatide attenuates ROS‐mediated vascular endothelial progenitor cell damage and mitochondrial dysfunction via SIRT3/Foxo3 signaling pathway.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 11, p. 1, doi. 10.1002/jbt.23452

By:

Yuan, Junfang;
Wang, Yuzhong;
Wang, Defeng;
Yan, Han;
Wang, Ning

Publication type:

Article

Changes in the expression levels of CB1 and GLP‐1R mRNAs and microRNAs 33a and 122 in the liver of type 2 diabetic rats treated with ghrelin.

Published in:

Journal of Biochemical & Molecular Toxicology, 2019, v. 33, n. 10, p. N.PAG, doi. 10.1002/jbt.22388

By:

Coskun, Zeynep M.;
Beydogan, Alisa B.;
Bolkent, Sema

Publication type:

Article

Functional evaluations comparing Billroth I with a large remnant stomach and Roux en Y with a small remnant stomach following laparoscopic distal gastrectomy for gastric cancer: An investigation including laparoscopic total gastrectomy.

Published in:

Surgery Today, 2023, v. 53, n. 2, p. 232, doi. 10.1007/s00595-022-02557-w

By:

Nomura, Eiji;
Seki, Takatoshi;
Ninomiya, Yamato;
Izumi, Hideki;
Yamamoto, Soichiro;
Nabeshima, Kazuhito;
Nakamura, Kenji;
Mukai, Masaya;
Makuuchi, Hiroyasu

Publication type:

Article

Plant foods, healthy plant-based diets, and type 2 diabetes: a review of the evidence.

Published in:

Nutrition Reviews, 2024, v. 82, n. 7, p. 929, doi. 10.1093/nutrit/nuad099

By:

Jiménez, Mariana del Carmen Fernández-Fígares

Publication type:

Article

Effects of whole grain intake on glucagon-like peptide 1 and glucose-dependent insulinotropic peptide: a systematic review and meta-analysis.

Published in:

Nutrition Reviews, 2023, v. 81, n. 4, p. 384, doi. 10.1093/nutrit/nuac056

By:

Hassanzadeh-Rostami, Zahra;
Ghobadi, Saeed;
Faghih, Shiva

Publication type:

Article

look on food intake and satiety: from humans to rodent models.

Published in:

Nutrition Reviews, 2022, v. 80, n. 8, p. 1942, doi. 10.1093/nutrit/nuac010

By:

Costa, Daniela G;
Almeida, Cláudia;
Cavadas, Cláudia;
Carmo-Silva, Sara

Publication type:

Article

Effect of sucralose and aspartame on glucose metabolism and gut hormones.

Published in:

Nutrition Reviews, 2020, v. 78, n. 9, p. 725, doi. 10.1093/nutrit/nuz099

By:

Ahmad, Samar Y;
Friel, James K;
Mackay, Dylan S

Publication type:

Article

Oral and intestinal sweet and fat tasting: impact of receptor polymorphisms and dietary modulation for metabolic disease.

Published in:

Nutrition Reviews, 2015, v. 73, n. 5, p. 318, doi. 10.1093/nutrit/nuu026

By:

Cvijanovic, Nada;
Feinle-Bisset, Christine;
Young, Richard L.;
Little, Tanya J.

Publication type:

Article

Taste perception, associated hormonal modulation, and nutrient intake.

Published in:

Nutrition Reviews, 2015, v. 73, n. 2, p. 83, doi. 10.1093/nutrit/nuu009

By:

Loper, Hillary B.;
La Sala, Michael;
Dotson, Cedrick;
Steinle, Nanette

Publication type:

Article

Intermittent versus continuous enteral nutrition attenuates increases in insulin and leptin during short-term bed rest.

Published in:

2020

By:

Gonzalez, Javier T.;
Dirks, Marlou L.;
Holwerda, Andrew M.;
Kouw, Imre W. K.;
van Loon, Luc J. C.

Publication type:

journal article

Recombinant production of mGLP-1 by coupling of refolding and intein-mediated self-cleavage (CRIS).

Published in:

Applied Microbiology & Biotechnology, 2012, v. 96, n. 5, p. 1283, doi. 10.1007/s00253-012-4163-4

By:

Gao, Mingming;
Tong, Yue;
Tian, Hong;
Gao, Xiangdong;
Yao, Wenbing

Publication type:

Article

Semaglutide 7.2 mg Achieves Weight Reduction of 21% in Late-Stage STEP UP Trial.

Published in:

Patient Care (Online), 2025, p. 1

By:

Halsey, Grace

Publication type:

Article

Viking Therapeutics Launches Phase 2 Trial for Oral VK2735 in Patients with Obesity.

Published in:

Patient Care (Online), 2025, p. 3

By:

Jennings, Sydney

Publication type:

Article

Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

Antiobesity Medications May Help Lower Alcohol Use, New Study Suggests.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management.

Published in:

Patient Care (Online), 2024, p. 3

By:

Jennings, Sydney

Publication type:

Article

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

ObesityWeek 2024: Viking Therapeutics Presents New Positive Data from VK2735 Obesity Program: Results from the VENTURE phase 2 trial and a phase I oral formulation study found that VK2735, a dual GLP-1 and GIP receptor agonist, demonstrated promise in treating obesity

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D.

Published in:

Patient Care (Online), 2024, p. 4

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs Reduce Suicide Risk in Youth with Obesity: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Exclusive Physician Survey Results on GLP-1 Receptor Agonists: The Hype Is Real.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article